{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:22:17Z","timestamp":1787955737328,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.prp.2024.155541","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:45:44Z","timestamp":1723736744000},"page":"155541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Expression and prognosis of DSG-2, CXADR, CD46 in head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"262","author":[{"given":"Inga Marte Charlott","family":"Seuthe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ruwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Silling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ehrke-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Jae-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155541_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.prp.2024.155541_bib2","unstructured":"Robert-Koch-Institut. Cancer in Germany 2017\/2018. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/kid_2021\/krebs_in_deutschland_2021.pdf;jsessionid=E4C80CEF760D28A18D7E716BEA66AF5E.internet112?__blob=publicationFile; Stand: 11.08.2023."},{"key":"10.1016\/j.prp.2024.155541_bib3","series-title":"Kompendium Internistische Onkologie. Standards in Diagnostik und Therapie. Teil 2. Therapiekonzepte maligner Tumoren","first-page":"3342","article-title":"Mundh\u00f6hlen- und Oropharynxtumoren","author":"Heermann","year":"2006"},{"key":"10.1016\/j.prp.2024.155541_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"ZurHausen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2024.155541_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2024.155541_bib6","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.2147\/OTT.S136367","article-title":"The role of desmosomes in carcinogenesis","volume":"10","author":"Zhou","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155541_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00784-023-05425-0","article-title":"Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis","volume":"28","author":"Fons\u00eaca","year":"2023","journal-title":"Clin. Oral. Investig."},{"key":"10.1016\/j.prp.2024.155541_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01292-x","article-title":"DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer","volume":"20","author":"Qin","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2024.155541_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104592","article-title":"Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma","volume":"103","author":"Cury","year":"2020","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.prp.2024.155541_bib10","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1096\/fj.201601138RR","article-title":"Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes","volume":"31","author":"Overmiller","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.prp.2024.155541_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcms.2021.11.015","article-title":"Desmoglein-3 overexpression in oral squamous cell carcinoma is associated with metastasis formation and early recurrence: An immunohistochemical study","volume":"50","author":"Troeltzsch","year":"2022","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"10.1016\/j.prp.2024.155541_bib12","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.prp.2024.155541_bib13","doi-asserted-by":"crossref","first-page":"15191","DOI":"10.1073\/pnas.261452898","article-title":"The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction","volume":"98","author":"Cohen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2024.155541_bib14","first-page":"1057","article-title":"Coxsackie adenovirus receptor expression in carcinomas of the head and neck","volume":"32","author":"Wunder","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2024.155541_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.oooo.2019.08.013","article-title":"Expression and clinicopathologic significance of coxsackie\u2013adenovirus receptor in oral squamous cell carcinoma","volume":"129","author":"Chen","year":"2020","journal-title":"Oral. Surg., Oral. Med., Oral. Pathol. Oral. Radiol."},{"key":"10.1016\/j.prp.2024.155541_bib16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1357-2725(99)00092-8","article-title":"Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions","volume":"31","author":"Seya","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2024.155541_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092694","article-title":"Targeting CD46 enhances anti-tumoral activity of adenovirus type 5 for bladder cancer","volume":"19","author":"Do","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155541_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.121497","article-title":"Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer","volume":"3","author":"Su","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.prp.2024.155541_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-0714.2006.00466.x","article-title":"Expression of complement restriction factors (CD46, CD55 und CD 59) in head and neck squamous cell carcinomas","volume":"35","author":"Ravindranath","year":"2006","journal-title":"J. Oral. Pathol. Med"},{"key":"10.1016\/j.prp.2024.155541_bib20","unstructured":"Amin M.B., Gress D.M., Meyer Vega L.R., Edge S.B., Greene F.L., Byrd D.R., Brookland R.K., Washington M.K., Compton C.C. American Joint committee on cancer Staging Manual, Eighth Edition. 8. American College of surgeons; 2018."},{"key":"10.1016\/j.prp.2024.155541_bib21","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/bjc.2013.509","article-title":"Presence of the Coxsackievirus and Adenovirus Receptor (CAR) in human neoplasms: a multitumour array analysis","volume":"109","author":"Reeh","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155541_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/PAI.0b013e31821a0be9","article-title":"CD46 expression is an unfavorable prognostic factor in breast cancer cases","volume":"19","author":"Maciejczyk","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2024.155541_bib23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ijc.10232","article-title":"Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II\/III and viral clearance","volume":"98","author":"Van Duin","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2024.155541_bib24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1128\/JCM.02227-07","article-title":"Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers","volume":"46","author":"Schmitt","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.prp.2024.155541_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00430-016-0475-9","article-title":"High prevalence of human papillomaviruses in Ghanaian pregnant women","volume":"205","author":"Schulze","year":"2016","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.prp.2024.155541_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/JCM.44.2.504-512.2006","article-title":"Bead-based multiplex genotyping of human papillomaviruses","volume":"44","author":"Schmitt","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.prp.2024.155541_bib27","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.ejca.2006.03.024","article-title":"Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma","volume":"42","author":"Yashiro","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2024.155541_bib28","first-page":"3397","article-title":"Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma","volume":"60","author":"Takebayashi","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155541_bib29","first-page":"5481","article-title":"Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients","volume":"22","author":"Han","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2024.155541_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00432-016-2250-0","article-title":"Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2","volume":"143","author":"Cai","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155541_bib31","first-page":"1","article-title":"Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods","volume":"2020","author":"Sun","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.prp.2024.155541_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7314\/APJCP.2014.15.2.871","article-title":"Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma","volume":"15","author":"Fang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2024.155541_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113416","article-title":"Up-regulation of Dsg2 confered stem cells with malignancy through wnt\/ \u03b2-catenin signaling pathway","volume":"422","author":"Chen","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2024.155541_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9831646","article-title":"Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma","volume":"2020","author":"Xu","year":"2020","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.prp.2024.155541_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098786","article-title":"Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer","volume":"9","author":"Barber","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prp.2024.155541_bib36","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/mc.22644","article-title":"Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells","volume":"56","author":"H\u00fctz","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2024.155541_bib37","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/15384047.2020.1843323","article-title":"Desmoglein-2 as a prognostic and biomarker in ovarian cancer","volume":"21","author":"Kim","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2024.155541_bib38","article-title":"A five-genes-based prognostic signature for cervical cancer overall survival prediction","volume":"2020","author":"Zhao","year":"2020","journal-title":"Int. J. Genom."},{"key":"10.1016\/j.prp.2024.155541_bib39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/onc.2013.66","article-title":"Coxsackie and adenovirus receptor is a critical regulator for the survival and growth of oral squamous carcinoma cells","volume":"33","author":"Saito","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155541_bib40","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/bjc.2011.116","article-title":"Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer","volume":"104","author":"Stecker","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155541_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.urology.2005.02.033","article-title":"Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer","volume":"66","author":"Matsumoto","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.prp.2024.155541_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.bjc.6604876","article-title":"Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression","volume":"100","author":"Anders","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155541_bib43","doi-asserted-by":"crossref","unstructured":"Suominen E, Toivonen R, Grenman R, Savontaus M. Head and neck cancer cells are efficiently infected by Ad5\/35 hybrid virus. Journal of Gene Medicine 2012; 8: 1223\u20131231. doi:10.1002\/jgm.","DOI":"10.1002\/jgm.957"},{"key":"10.1016\/j.prp.2024.155541_bib44","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ejca.2014.05.005","article-title":"The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack","volume":"50","author":"Kesselring","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2024.155541_bib45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/1541-7786.MCR-06-0352","article-title":"Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity","volume":"5","author":"Buettner","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.prp.2024.155541_bib46","first-page":"4943","article-title":"CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients","volume":"26","author":"Surowiak","year":"2006","journal-title":"Anticancer Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824004527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824004527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:49:17Z","timestamp":1727185757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824004527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":46,"alternative-id":["S0344033824004527"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155541","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and prognosis of DSG-2, CXADR, CD46 in head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155541"}}